TEchnology
The NeuralGlider® Precision Brain Access Platform
A developed and preclinically validated platform that uses electronically controlled ultrasonic motion to help maintain the desired trajectory during insertion through delicate brain tissue.
- NDeep brain targets require precision
- NElectronically controlled ultrasonic motion for access
- NDesigned for access, placement, and delivery
- NTrajectory control during insertion — not navigation
- NDeveloped and validated in multiple preclinical studies
The platform does not replace surgical planning, imaging, or navigation. It improves the physical insertion process by helping maintain the desired trajectory through brain tissue.
Evidence by the numbers
A network of research, publications, and validated results built over more than a decade.
Evidence
A Strong Scientific Foundation for Clinical Translation
More than a decade of development, federal funding, preclinical validation, global research adoption, peer-reviewed publications, and issued patents support the NeuralGlider platform.
- NPreclinical validation across multiple studies
- N44+ peer-reviewed publications citing NeuralGlider
- N41+ global brain research laboratories using the technology
- N15 issued U.S. and international patents
- N $18M+ in NIH SBIR and DARPA competitive awards
A decade of federally funded development and independent research adoption supports translation to clinical use.
Publications
Peer-reviewed publications citing NeuralGlider®
Global brain research laboratories using the technology
Scientific Publications and Research Foundation
Research Areas
- NPrecision brain access and trajectory control
- NAAV gene therapy delivery to deep brain targets
- NReduced tissue trauma and therapeutic reflux
- NSmaller-diameter cannula delivery methods
- NDeep brain stimulation and neural interface access
Applications
Enabling Multiple Categories of Brain-Directed Therapies
Deep Brain Stimulation
Precise lead and electrode placement into deep nuclei to support consistent, well-targeted neuromodulation therapy.
Epilepsy Monitoring & Therapy
Accurate access for depth electrodes and localized therapy delivery in seizure-focus mapping and treatment.
CNS Gene Therapy
Targeted AAV and vector delivery to deep brain structures, demonstrated in non-human primate studies.
Brain-Delivered Biologics
Controlled delivery of proteins and biologic payloads with smaller-diameter cannulas that may reduce reflux.
Neural Interfaces & BCI
Stable, low-trauma insertion of probes and interface arrays for next-generation brain–computer systems.
Regenerative & Restorative Therapies
Precise placement of cell-based and restorative therapeutics into targeted deep brain regions.